trending Market Intelligence /marketintelligence/en/news-insights/trending/r0ahhbt1fpphovdvb-sdtg2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us
In This List

Verrica Pharmaceuticals prices $75M IPO


Needham & Company is Now Available in the S&P Global Market Intelligence Aftermarket Research Collection


Banking Essentials Newsletter - February Edition


Message in a (Word)Cloud

Six trends shaping the industries and sectors we cover in 2021

Verrica Pharmaceuticals prices $75M IPO

Verrica Pharmaceuticals Inc. priced its IPO of 5 million common shares at $15 apiece to raise gross proceeds of about $75 million.

The company has also granted the underwriters an option to buy up to an additional 750,000 shares.

Verrica said the shares are scheduled to start trading on the Nasdaq Global Market on June 15 under the ticker symbol VRCA.

The offering is expected to close June 19.

Bank of America Merrill Lynch, Jefferies and Cowen are serving as joint book-running managers for the offering.